These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19254577)

  • 1. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What agent should be used to prevent recurrent preterm birth: 17-P or natural progesterone?
    Hall NR
    Obstet Gynecol Clin North Am; 2011 Jun; 38(2):235-46, ix-x. PubMed ID: 21575799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of preterm delivery with gestagens].
    Schindler AE
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of progesterone to prevent preterm birth at a tertiary care center.
    Bailit JL; Berkowitz R; Thorp JM; Cleary K; Hartmann KE; Mercer BM
    J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice.
    Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella
    Am J Obstet Gynecol; 2012 May; 206(5):376-86. PubMed ID: 22542113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.
    Dodd JM; Ashwood P; Flenady V; Jenkins-Manning S; Cincotta R; Crowther CA
    Aust N Z J Obstet Gynaecol; 2007 Apr; 47(2):106-9. PubMed ID: 17355298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: a novel mechanism to explain progesterone-mediated prevention of preterm birth.
    Luo G; Abrahams VM; Tadesse S; Funai EF; Hodgson EJ; Gao J; Norwitz ER
    Reprod Sci; 2010 Jun; 17(6):532-9. PubMed ID: 20360593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM; Lewis DF
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestational agents for the prevention of preterm birth.
    Lamont RF; Jayasooriya GS
    J Perinat Med; 2009; 37(1):12-4. PubMed ID: 18999914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction and prevention of recurrent spontaneous preterm birth.
    Spong CY
    Obstet Gynecol; 2007 Aug; 110(2 Pt 1):405-15. PubMed ID: 17666618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progesterone for prevention of preterm delivery: only in trial setting].
    Lim AC; Mol BW; Bruinse HW
    Ned Tijdschr Geneeskd; 2010; 154():A1730. PubMed ID: 20858311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM; Prescott GM; Franco A; Fan-Havard P
    Ann Pharmacother; 2013 Apr; 47(4):527-36. PubMed ID: 23535817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From concept to practice: the recent history of preterm delivery prevention. Part II: Subclinical infection and hormonal effects.
    Vidaeff AC; Ramin SM
    Am J Perinatol; 2006 Feb; 23(2):75-84. PubMed ID: 16506112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction and prevention of spontaneous preterm birth in twin gestations.
    Brubaker SG; Gyamfi C
    Semin Perinatol; 2012 Jun; 36(3):190-4. PubMed ID: 22713500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes and practices regarding use of progesterone to prevent preterm births.
    Henderson ZT; Power ML; Berghella V; Lackritz EM; Schulkin J
    Am J Perinatol; 2009 Aug; 26(7):529-36. PubMed ID: 19301227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic antibiotics for the prevention of preterm birth in women at risk: a meta-analysis.
    Simcox R; Sin WT; Seed PT; Briley A; Shennan AH
    Aust N Z J Obstet Gynaecol; 2007 Oct; 47(5):368-77. PubMed ID: 17877593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent preterm birth in women treated with 17 α-hydroxyprogesterone caproate: the contribution of risk factors in the penultimate pregnancy.
    Coleman S; Wallace L; Alexander J; Istwan N
    J Matern Fetal Neonatal Med; 2012 Jul; 25(7):1034-8. PubMed ID: 21854134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerclage, progesterone and α-hydroxyprogeterone caproate treatment in women at risk for preterm delivery.
    Haram K; Mortensen JH; Morrison JC
    J Matern Fetal Neonatal Med; 2014 Nov; 27(16):1710-5. PubMed ID: 24678618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric management of moderate and late preterm labour.
    McParland PC
    Semin Fetal Neonatal Med; 2012 Jun; 17(3):138-42. PubMed ID: 22410256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F; Vaccaro V
    Minerva Ginecol; 2009 Oct; 61(5):401-9. PubMed ID: 19749671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.